Congress Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-148,679
Closed -$10.2M 1188
2025
Q1
$10.2M Sell
148,679
-20,659
-12% -$1.69M 0.12% 198
2024
Q4
$13.2M Buy
169,338
+151,796
+865% +$11.2M 0.18% 165
2024
Q3
$1.18M Sell
17,542
-159,296
-90% -$13.1M 0.02% 496
2024
Q2
$20M Buy
176,838
+8,181
+5% +$1.03M 0.32% 79
2024
Q1
$23.4M Buy
168,657
+952
+0.6% +$120K 0.4% 59
2023
Q4
$20.8M Buy
167,705
+141,065
+530% +$14.4M 0.38% 55
2023
Q3
$2.49M Sell
26,640
-2,174
-8% -$245K 0.05% 277
2023
Q2
$3.7M Sell
28,814
-318
-1% -$38.5K 0.09% 221
2023
Q1
$3.38M Sell
29,132
-4,267
-13% -$478K 0.08% 225
2022
Q4
$3.78M Sell
33,399
-4,397
-12% -$483K 0.1% 203
2022
Q3
$3.04M Sell
37,796
-12,256
-24% -$1.04M 0.08% 231
2022
Q2
$3.73M Sell
50,052
-13,588
-21% -$1.24M 0.1% 216
2022
Q1
$8.14M Buy
63,640
+188
+0.3% +$20.6K 0.18% 164
2021
Q4
$8.52M Buy
+63,452
New +$9.12M 0.17% 170

Other funds holding DXCM

Congress Wealth Management's DXCM Position: Q2 2025 in Review

Congress Wealth Management sold out of DexCom (DXCM) in Q2 2025, closing a stake of 148,679 shares — an estimated $10.2M sold.

Congress Wealth Management first reported a position in DXCM in Q4 2021 and held it in 14 quarters. The position peaked at $23.4M in Q1 2024. 939 funds tracked by Wall St. Rank hold DXCM as of Q2 2025.

  • Congress Wealth Management reported no remaining DexCom position as of Q2 2025 after selling out during the quarter.
  • Congress Wealth Management sold 148,679 DexCom shares in Q2 2025, an estimated $10.2M.
  • Congress Wealth Management first reported a position in DexCom in Q4 2021 and held it in 14 quarters.
  • Congress Wealth Management's DexCom position peaked at $23.4M in Q1 2024.
  • 939 funds tracked by Wall St. Rank held DexCom as of Q2 2025.

Based on Congress Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.